Science

Common drugs can help harmful bacteria spread throughout the body

Medicines are designed to treat diseases and relieve symptoms, but some can produce unintended side effects that put patients at risk. Although side effects are common with many treatments, researchers have identified a potential factor involving drugs used to control inflammation.

Scientists at the Norwegian University of Science and Technology (NTNU) have discovered that a widely used class of anti-inflammatory drugs can make it easier for certain viruses to infect cells and spread throughout the body.

“We found a surprising and potentially dangerous effect of a class of anti-inflammatory drugs. They can help bacteria spread easily in the body,” said Denis Kainov, professor at the Department of Medicine and Molecular Medicine at the Norwegian University of Science and Technology (NTNU).

Common Anti-Inflammatory Drugs May Help Viruses Spread

The drugs at the center of that discovery belong to a class called Janus kinase inhibitors, or JAKs. These drugs are widely prescribed to control inflammation, but their effects on the immune system may leave the body more vulnerable to viral infections.

“Among the viruses that easily affect the body with the help of these drugs are Rift Valley fever virus, influenza A, adenovirus and SARS-CoV-2, the virus that causes COVID-19,” said Kainov.

These viruses can cause serious illness, making any treatment that may increase their ability to spread a serious concern.

Why Arthritis Drugs Can Weak Antiviral Defenses

In a new study published in NAR Molecular Medicine, Kainov and his colleagues investigated how JAK inhibitors influence the body’s ability to defend itself against viruses.

“JAK inhibitors are often prescribed for autoimmune diseases and inflammatory conditions such as rheumatoid arthritis,” said Erlend Ravlo, PhD researcher at NTNU and first author of this article.

Although these drugs can be very effective in reducing inflammation, their benefits come with important trade-offs. By suppressing certain immune responses, they can also interfere with mechanisms that normally protect the body from viral infections.

“In particular, the drugs suppress an important immune system that helps protect healthy cells from viral attack,” Ravlo said.

This pathway plays an important role in coordinating the body’s response when pathogens attempt to infect healthy tissue.

Scientists Discover How JAK Inhibitors Interfere With Immune Defenses

The research team found that JAK inhibitors, including the drug baricitinib, can reduce the activity of genes involved in fighting viral infections.

“These genes play an important role in the body’s response to viral infections,” said Aleksandr Ianevski, NTNU researcher and author of the new paper.

When JAK inhibitors interfere with this immune signaling system, they weaken an important layer of defense against viruses. Without a normal immune response, bacteria can find it easier to establish an infection and spread between cells.

To investigate these results, scientists combined advanced methods of virology and gene expression analysis and organoid technology. Their experiments included cells from the lungs, eyes and brain, as well as models of a small organ grown in the laboratory.

These methods allowed the team to test how the drugs affect the immune system in different types of human tissue.

“Although JAK inhibitors are effective in treating inflammation, this shows that they may pose a hidden risk in patients with latent or active viral infections,” said Ravlo.

What the Findings Mean for Patients and Future Treatment

The results highlight the importance of carefully considering the risks associated with JAK inhibitors, especially when patients may already have a viral infection or when infections develop.

The researchers suggest that health care professionals should be careful when prescribing these drugs during times of increased transmission.

However, the same immunosuppressive properties that pose potential risks to patients may also provide benefits in certain research settings. Under controlled laboratory conditions, these results may help scientists develop vaccines or test potential antiviral drugs.

The researchers hope that their findings will promote greater awareness of how JAK inhibitors influence the immune system and support further investigation into their safer and more effective use.

“We recommend further research to better understand how the drugs can be used appropriately, especially during an outbreak or pandemic,” Ianevski said.

Professor Magnar Bjørås from the Department of Medicine and Chemistry provided valuable scientific expertise and secured many research grants. Additional financial support came from the Central Norway Regional Health Authority, South-Eastern Norway Regional Health Authority, Research Council of Norway and the Swedish Research Council.


Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button